References
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Melanoma. Version 3.2018. Washington: National Comprehensive Cancer Network; 2018.
Dummer R, Hauschild A, Lindenblatt N, Pentheroudakis G, Keilholz U, ESMO Guidelines Committee. Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl 5):v126–32.
Ahmadi O, Das M, Hajarizadeh B, Mathy JA. Impact of shave biopsy on diagnosis and management of cutaneous melanoma: a systematic review and meta-analysis. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-09866-3.
Zager JS, Hochwald SN, Marzban SS, et al. Shave biopsy is a safe and accurate method for the initial evaluation of melanoma. J Am Coll Surg. 2011;212(4):454–60.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
The authors have no conflicts of interest to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ahmadi, O., Mathy, J.A. ASO Author Reflections: Diagnosis of Melanoma Using Shave Biopsy has Minimal Impact on Tumor Staging and Treatment and Does Not Influence Patient Outcomes. Ann Surg Oncol 28, 6177–6178 (2021). https://doi.org/10.1245/s10434-021-09935-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-021-09935-7